# Assisting Smokers to Switch to an e-Cigarette by Accelerating Learning of Adaptive Habits Using D-cycloserine

> **NCT05994703** · PHASE2 · COMPLETED · sponsor: **Rose Research Center, LLC** · enrollment: 25 (actual)

## Conditions studied

- Smoking Cessation
- Harm Reduction

## Interventions

- **DRUG:** d-cycloserine
- **OTHER:** Juul e-cigarette

## Key facts

- **NCT ID:** NCT05994703
- **Lead sponsor:** Rose Research Center, LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-10-20
- **Primary completion:** 2025-10-13
- **Final completion:** 2026-01-12
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2026-01-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05994703

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05994703, "Assisting Smokers to Switch to an e-Cigarette by Accelerating Learning of Adaptive Habits Using D-cycloserine". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05994703. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*